Related Experiment Video
Updated: Aug 11, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Epoetin alfa for predialysis and AZT-treated HIV-positive patients
Abstract:
PROCRIT is an exogenous form of erythropoietin now marketed for use in anemic predialysis patients and AZT-treated HIV-positive patients. It is the same preparation as epogen. It will be up to the physician to determine which form of the drug is prescribed for each patient. Cost issues will probably be a deciding factor as the products are identical. Key differences to keep in mind are that predialysis patients will have to come in to the clinic two or three times a week for injections as they are are not on dialysis and that payment issues could be a problem.
Related Concept Videos
Retrovirus Life Cycles
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
Hemodialysis III: Nursing Management

